These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1116 related items for PubMed ID: 750606

  • 1. Vitamin D metabolites and bone mineralization in man.
    Bordier P, Rasmussen H, Marie P, Miravet L, Gueris J, Ryckwaert A.
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of vitamin D: current status.
    DeLuca HF.
    Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 5. The effect of vitamin D on bone in vivo.
    Tam CS, Heersche JN, Jones G, Murray TM, Rasmussen H.
    Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
    [Abstract] [Full Text] [Related]

  • 6. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P, Zingraff J, Gueris J, Jungers P, Marie P, Pechet M, Rasmussen H.
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in our understanding of the vitamin D endocrine system.
    De Luca HF.
    J Lab Clin Med; 1976 Jan; 87(1):7-26. PubMed ID: 173767
    [Abstract] [Full Text] [Related]

  • 8. The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.
    Bikle DD, Rasmussen H.
    J Clin Invest; 1975 Feb; 55(2):292-8. PubMed ID: 236326
    [Abstract] [Full Text] [Related]

  • 9. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P.
    Miner Electrolyte Metab; 1985 Feb; 11(6):358-68. PubMed ID: 3877862
    [Abstract] [Full Text] [Related]

  • 10. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ, Travers R, Glorieux FH.
    Calcif Tissue Int; 1982 Mar 01; 34(2):158-64. PubMed ID: 6282410
    [Abstract] [Full Text] [Related]

  • 13. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR, Baylink DJ, Jones PG, Haussler MR.
    J Clin Invest; 1976 Jul 01; 58(1):61-70. PubMed ID: 1084355
    [Abstract] [Full Text] [Related]

  • 14. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb 01; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 15. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Feb 01; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 16. Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats.
    Lian JB, Carnes DL, Glimcher MJ.
    Endocrinology; 1987 May 01; 120(5):2123-30. PubMed ID: 3494594
    [Abstract] [Full Text] [Related]

  • 17. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.
    Yamato H, Matsumoto T, Fukumoto S, Ikeda K, Ishizuka S, Ogata E.
    Endocrinology; 1989 Jan 01; 124(1):511-7. PubMed ID: 2783309
    [Abstract] [Full Text] [Related]

  • 18. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL, Felsenfeld AJ, Llach F.
    Arch Intern Med; 1983 Jun 01; 143(6):1205-11. PubMed ID: 6344827
    [Abstract] [Full Text] [Related]

  • 19. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E, Kreusser W, Boland R, Bommer J.
    Klin Wochenschr; 1979 Oct 01; 57(19):1053-9. PubMed ID: 392179
    [Abstract] [Full Text] [Related]

  • 20. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK, Thomsen K, Eriksen EF, Charles P, Storm T, Mosekilde L.
    Bone Miner; 1988 Apr 01; 4(1):105-13. PubMed ID: 3263890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.